BEGIN:VCALENDAR VERSION:2.0 PRODID:-//jEvents 2.0 for Joomla//EN CALSCALE:GREGORIAN METHOD:PUBLISH BEGIN:VTIMEZONE TZID:America/Los_Angeles X-LIC-LOCATION:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:19700308T020000 RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:19701101T020000 RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU END:STANDARD END:VTIMEZONE BEGIN:VEVENT UID:6460b6291d7459e812e8b1092370e92d472 CATEGORIES:Fall Seminar SUMMARY:2023 OSHP Fall Seminar DESCRIPTION:
We are excited to a nnounce that this year's Seminar will be held on November 4, 2023 at the OH SU-Robertson Life Sciences Building in Portland, Oregon.
Seminar Event Detai
ls
November 4, 2023
2730 S Moody Ave
Portland, OR 97201<
/span>
CE Credit
This activity h
as been planned and implemented in accordance with the policies of the Accr
editation Council on Pharmacy Education (ACPE) through the joint providersh
ip of the Oregon State University College of Pharmacy and Oregon Society fo
r Health-System Pharmacists (OSHP). Oregon State University College of Phar
macy is accredited by the Accreditation Council for Pharmacy Education as a
provider of continuing pharmacy education. This program has been approved
for up to 5 hour(s) of ACPE accredited continuing pharmacy education.
Disclosur es: None of the planners or presenters for this program have any f inancial relationships with ineligible companies to disclose.
An ACPE Statement of Cred it shall be issued to participants only after successful completion of the activity. Internet access is required for successful completion. Successful completion is defined as: 1) Attending, in its entirety, the CPE activity and receiving the unique activity Credit Code; 2) Participating in the pre- test administered by the presenter(s); 3) Completing the online activity ev aluation and self-evaluation quiz located at:http://phar macy.oregonstate.edu/ce within 60 days of program attendance. The State ment of Credit will be uploaded to the participant’s CPE Monitor automatica lly within 48 hours of successful activity completion. It is the participan t’s responsibility to complete the online components (Step 3) within 60 day s of program attendance. Credit will not be provided after 60 days.
Registration
Your registration includes: All education sessions and materials,
access to exhibits, continental breakfast, lunch and refreshment breaks. <
/p>
Seminar Schedule*
7:30 - 8:00
am
Registration/Visit with Exhibitors
Opening Remarks
8:15 - 9:15 am
(General Session)
Race-based prescribing for Black and African Americ
an Individuals with High Blood Pressure: Is it time for a change?
Presented by Abby Frye PharmD
Historically, treatment gu
idelines have recommended differential treatment of hypertension based on r
ace. More specifically, these guidelines have recommended that Black and Af
rican American individuals without comorbidities should receive either a th
iazide diuretic or a calcium channel blocker as initial therapy, while angi
otensin-converting enzyme inhibitors and/or angiotensin receptor blockers s
hould only be considered as initial therapy for Black and African American
individuals with certain comorbidities such as chronic kidney disease. Rece
nt studies indicate that these guidelines have affected clinical practice,
but despite the use of more “evidence-based” monotherapies in Black and Afr
ican American individuals the racial disparity in hypertension control is g
rowing. This session will examine the available evidence regarding how and
if we should be using race and other factors to guide the treatment of hype
rtension.
UAN: 0036-9999-23-229-L01-P/0036-9999-23-23
0-L01-T
Audience: RPh and CPT
Activity-T
ype: Application-based for RPh; Knowledge-based for CPT
Credit Hours: 1.0
RPh Le
arning Objectives:
CPT Learning Objectives:
9:15-9:35 am
Visit with E
xhibitors
9:35-10:35 am (Pharmacist Tr
ack)
Statewide Formulary, Novel Practices with Reimbu
rsement
Presented by Lorinda Anderson PharmD, BCP
S & Amy Valdez RPh
An update on the Oregon Public He
alth and Pharmacy Formulary Advisory Committee that makes recommendations o
n statewide protocols to the board of pharmacy. These protocols allow pharm
acists to autonomously prescribe within their parameters and have increased
pharmacist scope of practice within the state. We will review protocols cu
rrently approved and what the committee has been working on recently.
UAN: 0036-9999-23-221-L03-P/T
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic
Designation: Law Related to Pharmacy Practice
Credit
Hours: 1.0
Learning Objectives:
9:35-10:35 am (Technician Track)
Prior Authorization & REMS
Present
ed by Binh Tran CPhT, B.S. & Allison Mishkin CPhT
Wh
at is Prior Authorization in Healthcare? What is Prior Authorization in the
Pharmacy world? How does Medication Prior Authorization affect oncology pa
tients specifically?
We will introduce the REMS Program and highlight
opportunities for CPhTs to get more involved.
UAN: 00
36-9999-23-227-L04-T
Audience: CPT
Activ
ity-Type: Application-based
Topic Designation: Pharmacy Administration
Credit Hours: 1.0
10:35-10:55 am
Visit wi
th Exhibitors
10:55-11:55 am (Pharmacist Track)
New CDC Opioid guidelines: What changed and What now for Pain?
Presented by Jessica Merlo PharmD, BCACP
<
/strong>The release of the 2016 CDC Guideline for Prescribing Opioids for C
hronic Pain had an incredible impact on the management of patients with chr
onic pain in the United States through changes seen in prescribing practice
s, insurance coverage, and regulations. Unfortunately, some of the changes
inflicted by this guideline resulted in negative outcomes due to misinterpr
etation of guideline language and lack of person-centered decision making.
With new data gathered, especially in relation to treatment of acute/subacu
te pain, the CDC recognized a need to provide more updated recommendations
for prescribing opioids to improve pain management and patient safety. This
presentation will review the impact of the 2016 guideline release, the rat
ionale for creating an updated guideline, the major changes to the guidelin
e, and how to incorporate this guideline into practice in order to make inf
ormed, individualized decisions about safe and effective treatment for pain
care.
UAN: 0036-9999-23-222-L05-P/0036-9999-23-223-L
05-T
Audience: RPh and CPT
Activity-Type
: RPh – Application-based; CPT – Knowledge-based
Topi
c Designation: Patient Safety
Credit Hours:
1.0
RPH Learning Objectives:
CPT Learning Objectives:
10:55-11:55 am (Technician Track)
Pre
sented by Angela Koerner PharmD, BCACP, Europa Babbini CPhT, <
/em>Kelli Johnson CPhT-Adv
Technician Ladder Implementation in Multiple Practice Settings
<
strong>UAN: 0036-9999-23-228-L99-T
Audience:
CPT
Activity-Type: Knowledge-based
Topi
c Designation: Additional Topic Areas
Credit Hours:
strong> 1.0
Learning Objectives
11:55 am -1:20 pm
Lunch with
Program
1:20-2:20 pm (General Session Track)
<
strong style="font-size: 20px;">Advances in the Management of Migraine
Presented by Kelsey Blom PharmD, BCACP
This presentation will review newly approved medications for acute and
prophylactic treatment of migraine, including monoclonal antibodies, CGRP
receptor antagonists, and the 5-HT1F receptor agonist. Patient cases will b
e incorporated to reinforce counseling points regarding use of medications,
drug interactions, and adverse effects of therapy.
UAN: 0036-9999-23-224-L01-P/T
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Desig
nation: Disease State Management/Drug Therapy
Credit
Hours: 1.0
RPh Learning Objectives:
CPT Learning Objectives:
Dynamic Inter
viewing Skills and Feedback
Presented by YoungYoo
n Ham PharmD BCIDP
This session will be
set up like a traditional classical music masterclass, with a number of st
udents being given a chance to answer a standard interview question. After
answering the question, student will be given immediate feedback with conc
rete recommendations about how the answer could be adjusted. Student will
then re-answer the same question, repeating the process as many times as ne
cessary to come to a satisfactory conclusion. Other students can learn fro
m the process while awaiting their turn.
2:25-3:25 pm (Genera
l Session)
Menopause Medicine: How Times Have Changed!
<
strong>Presented by Karen Adams MD
We review current
best practices for hormone therapy (HT) use, contraindications to HT, and
non hormonal options for patients in whom HT is contraindicated.
Audience: R
Ph and CPT
Activity-Type: Knowledge-basedCredit Hours: 1.0
RPh Learning Objectives:
CPT Learning Objectives:
3:25-3:45 pm
Break/Visit Posters
3:45-4:45 pm (General Session)
What's New in Screening and Treating Tobacco Use Disorder<
br />Presented by Julie Himstreet, PharmD
strong>This presentation will review evidence-based approaches for tobacco
use disorder. The 2021 US Preventative Services Task Force updated recommen
dations for tobacco cessation treatment will be overviewed. Opportunities f
or pharmacists to be involved in tobacco cessation treatment will be highli
ghted.
UAN: 0036-9999-23-226-L01-P/T
Aud
ience: RPh and CPT
Activity-Type: Knowledge-
based
Topic Designation: Disease State Management/Dru
g Therapy
Credit Hours: 1.0
Learning Obj
ectives:
End of Seminar
*Schedule and content subject to chan ge.
Going Green
In an
effort to minimize paper waste, course handouts will be available online a
t www.oshp.org one week prior to the Seminar. An email to access the mater
ials will be e-mailed to you on October 30th.
EXHIBIT OR SPONSOR AT THE
OSHP 2023 FALL SEMINAR!
The
Board of Directors of the Oregon Society of Health-System Pharmacists invit
es you to participate as a Sponsor or Exhibitor at the 2023 Fall Seminar!
span>
Exhibit Schedule
6:30 - 7:30 am | Exhibitor Set Up
7:30 - 8:00 am | Registration
8:00 am - 4:55 pm | Education
1:30 - 2:30
pm | Exhibitor Tear Down
Fall Seminar Exhibit/Sponsor Fees
< ul>Your exhibit registration includes a skirted display space, one chair and one lunch ticket. This is a ‘table top’ show, which means there is not drap ed off space for each exhibit, instead each exhibitor has the table space t o display their items.